Indications and guidelines for the use of hematopoietic growth factors.
Goodnough
L T
LT
Washington University School of Medicine, St. Louis, Missouri.
Anderson
K C
KC
Kurtz
S
S
Lane
T A
TA
Pisciotto
P T
PT
Sayers
M H
MH
Silberstein
L E
LE
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000740:Anemia / Q000209:etiology / Q000628:therapy; D016026:Bone Marrow Transplantation; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D007938:Leukemia / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000628:therapy; D009369:Neoplasms / Q000628:therapy
D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor